ZCM
ALXN

Ziegler Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Ziegler Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$227K Sell
1,955
-442
-18% -$48.5K 0.02% 385
2013
Q2 		$221K Buy
+2,397
New +$231K 0.02% 372

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ziegler Capital Management's ALXN Position: Q3 2013 in Review

Ziegler Capital Management reduced its Alexion Pharmaceuticals (ALXN) stake by 18% in Q3 2013, selling an estimated $48.5K and leaving 1,955 shares worth $227K. The position accounts for 0.02% of the portfolio, ranked #385.

Ziegler Capital Management first reported a position in ALXN in Q2 2013 and has held it in 2 quarters since. 437 funds tracked by Wall St. Rank hold ALXN as of Q3 2013.

  • Ziegler Capital Management held 1,955 shares of Alexion Pharmaceuticals worth $227K as of Q3 2013.
  • Ziegler Capital Management sold 442 Alexion Pharmaceuticals shares in Q3 2013, an estimated $48.5K.
  • Alexion Pharmaceuticals made up 0.02% of Ziegler Capital Management's portfolio in Q3 2013, its #385 holding.
  • Ziegler Capital Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 2 quarters since.
  • 437 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2013.

Based on Ziegler Capital Management's 13F filing for Q3 2013, filed 6 Nov 2013.